Skip to main content
logo
Mahamaya Lifesciences Limited (BOM:544611)
India flag India · Delayed Price · Currency is INR
183.00
-0.05 (-0.03%)
At close: Sep 25, 2026

Mahamaya Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3,2923,2922,6531,6161,371899.19
Revenue Growth
16.69%24.10%64.18%17.84%52.50%-
Gross Profit
544.89544.89384.27224.66186.77146.24
Operating Income
328.75328.75227.69119.9684.3154.62
Net Income
165.23165.23128.1253.7637.5127.23
Earnings Per Share
8.338.337.523.912.731.98
EPS Growth
6.16%10.80%92.09%43.36%37.88%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
393.99393.9939.9530.1430.4413.65
Total Debt
907.37907.37581.14546.26243.73191.65
Net Cash (Debt)
-513.38-513.38-541.19-516.11-213.28-178
Net Cash Growth
------
Net Cash Per Share
-25.88-25.88-31.76-37.57-15.53-12.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-295.24-295.24-4.27-234.611.2421.62
Capital Expenditures
-88.08-88.08-50.44-15.13-28.94-32.69
Free Cash Flow
-383.32-383.32-54.71-249.73-17.7-11.07
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
16.55%16.55%14.49%13.90%13.62%16.26%
Operating Margin
9.99%9.99%8.58%7.42%6.15%6.08%
Pretax Margin
7.25%7.25%6.50%4.60%3.72%4.14%
Profit Margin
5.02%5.02%4.83%3.33%2.73%3.03%
FCF Margin
-11.64%-11.64%-2.06%-15.46%-1.29%-1.23%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
21.9721.32----
PS Ratio
1.301.07----